Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	150.23	326.33	317.5	474.88	651.55	1,029
Short-Term Investments	808.94	509.69	591.22	658.47	696.8	366.3
Trading Asset Securities	-	-	-	18.66	17.77	19.65
Cash & Short-Term Investments	959.17	836.03	908.72	1,152	1,366	1,415
Cash Growth	-2.71%	-8.00%	-21.12%	-15.67%	-3.43%	-11.82%
Accounts Receivable	218.32	130.85	175.16	138.92	130.52	149.05
Other Receivables	9.59	4.52	2.61	2.8	1.84	2.06
Receivables	227.91	135.36	177.77	141.71	132.36	151.11
Inventory	148	168.54	161.79	188.76	115.2	115.18
Prepaid Expenses	22.19	24.31	12.21	16.43	3.84	7.84
Other Current Assets	2.82	2.89	8.26	125.78	2.04	2.13
Total Current Assets	1,360	1,167	1,269	1,625	1,620	1,691
Property, Plant & Equipment	28.24	30.62	29.51	7.65	14.54	22.51
Long-Term Investments	263.89	360.37	418.6	119.7	134.74	93.33
Other Intangible Assets	0.36	0.41	0.6	0.79	0.05	0.25
Long-Term Accounts Receivable	-	12.29	17.1	-	1.99	6.68
Long-Term Deferred Tax Assets	7.6	7.45	10.41	7.77	6.71	10.07
Other Long-Term Assets	23.52	12.46	4.81	4.83	5.63	7.33
Total Assets	1,684	1,591	1,750	1,765	1,783	1,831
Accounts Payable	44.79	29.8	25.9	62.69	46.71	89.95
Accrued Expenses	-	76.71	81	96.88	80.1	95.23
Current Portion of Leases	11.03	10.94	9.81	5.05	10.08	9.83
Current Income Taxes Payable	49.16	30.26	56.41	80.35	40.51	40.15
Current Unearned Revenue	19.45	21.6	11.52	8.26	8.05	13.59
Other Current Liabilities	180.03	35.26	68.57	35.65	33.75	30.42
Total Current Liabilities	304.47	204.56	253.2	288.88	219.18	279.16
Long-Term Leases	27.25	30.04	36.96	-	5.6	15.68
Long-Term Deferred Tax Liabilities	1.07	-	3.3	0.98	28.18	-
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.26	1.26
Total Liabilities	334.05	235.86	294.71	291.12	254.22	296.1
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	151.7	151.7	241.8	331.89	421.99	512.08
Retained Earnings	747.47	752.67	762.78	691.96	548.78	479.09
Comprehensive Income & Other	-	-	-	-	107.77	93.31
Shareholders' Equity	1,350	1,355	1,455	1,474	1,529	1,535
Total Liabilities & Equity	1,684	1,591	1,750	1,765	1,783	1,831
Total Debt	38.28	40.98	46.77	5.05	15.68	25.5
Net Cash (Debt)	920.89	795.05	861.95	1,147	1,350	1,389
Net Cash Growth	-2.19%	-7.76%	-24.85%	-15.07%	-2.78%	-11.54%
Net Cash Per Share	17.21	17.60	19.08	25.44	29.95	30.80
Filing Date Shares Outstanding	84.89	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	84.89	45.05	45.05	45.05	45.05	45.05
Working Capital	1,056	962.56	1,016	1,336	1,400	1,412
Book Value Per Share	15.90	30.08	32.30	32.73	33.94	34.07
Tangible Book Value	1,349	1,354	1,454	1,474	1,529	1,535
Tangible Book Value Per Share	15.89	30.07	32.29	32.71	33.94	34.07